MedPath

MOLECULIN LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis

Phase 2
Completed
Conditions
Psoriasis
Interventions
Drug: Placebo
First Posted Date
2013-04-08
Last Posted Date
2014-12-24
Lead Sponsor
Moleculin, LLC
Target Recruit Count
21
Registration Number
NCT01826201
Locations
🇺🇸

Minnesota Clinical Study Center, Fridley, Minnesota, United States

🇺🇸

International Dermatology Research, Inc., Miami, Florida, United States

🇺🇸

Academic Dermatology Associates, Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath